EMEA-EFPIA 'Quality by Design' application workshop Event Add to calendar Google Calendar Apple Calendar Office365 Calendar Outlook Calendar Yahoo Calendar
Date Pirmdiena, 28 Septembris 2009, Visu dienu Vieta European Medicines Agency, Amsterdam, the Netherlands Documents EMEA-EFPIA 'Quality by Design' application workshop - Introduction English (EN) (191.88 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Regulators perspective on 'Quality by Design': QWP perspective - Jean-Louis Robert English (EN) (147.16 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Regulators perspective on 'Quality by Design': GMP/GDP Inspectors Working Group - David Cockburn English (EN) (214.19 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Regulators perspective on 'Quality by Design': BWP perspective - Kowid Ho English (EN) (1.07 MB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Integrated application of a QbD Development Approach across Chemical and Formulation Manufacturing Process English (EN) (215.61 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Continuous Quality Verification: an approach to process validation English (EN) (289.64 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Use of in-line near-infrared spectroscopy to monitor segregation of a pharmaceutical powder blend in a tablet press English (EN) (463.1 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt The use of in vitro and in vivo data to define both design space and control strategy English (EN) (1.84 MB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt QbD Development (derivation of CQAs, CPPs and design space using quality risk assessment and design of experiments on a scale-down model of the manufacturing process) of a novel therapeutic protein English (EN) (204.46 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Utilisation of QbD principles for the management of post approval changes for a novel recombinant monoclonal antibody English (EN) (267.86 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Next steps & closing remarks - Fergus Sweeney, Mike James English (EN) (227.83 KB - PDF)Pirmo reizi publicēts: 28/09/2009 Pēdējo reizi atjaunināts: 28/09/2009 Skatīt Share this page